| Metric | სს ბიოფარმი | სს თიბისი ბანკი |
|---|---|---|
| Growth | ||
| Revenue | ₾10.1m₾9.7m | ₾2.36bn₾2.11bn |
| Revenue growth | 4.8% | 11.8% |
| Profitability | ||
| EBITDA | -₾847k-₾427k | — |
| EBITDA margin | -8.3%-4.4% | — |
| Net profit | -₾1.3m-₾1.1m | ₾1.24bn₾1.12bn |
| Net margin | -12.6%-11.5% | 52.8%53.0% |
| Balance sheet | ||
| Total assets | ₾19.1m₾18.5m | ₾37.66bn₾31.77bn |
| Total equity | ₾18.2m₾17.1m | ₾5.45bn₾4.75bn |
| ROE | -7.0%-6.5% | 22.8%23.6% |